Dr Reddy’s gearing up for Canada semaglutide launch, to expand India portfolio

Dr Reddy's Laboratories is set to launch a generic version of semaglutide in Canada, where it was the first to receive regulatory approval. The company is also expanding its oral semaglutide offering in India and plans to enter over 80 countries in the next two years.